JP3240345B2 - Oral hypnotics, hypnotic foods and drinks - Google Patents
Oral hypnotics, hypnotic foods and drinksInfo
- Publication number
- JP3240345B2 JP3240345B2 JP18234996A JP18234996A JP3240345B2 JP 3240345 B2 JP3240345 B2 JP 3240345B2 JP 18234996 A JP18234996 A JP 18234996A JP 18234996 A JP18234996 A JP 18234996A JP 3240345 B2 JP3240345 B2 JP 3240345B2
- Authority
- JP
- Japan
- Prior art keywords
- essential oil
- sleep
- food
- sandalwood
- drink
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 235000013305 food Nutrition 0.000 title claims description 46
- 239000003326 hypnotic agent Substances 0.000 title claims description 5
- 230000000147 hypnotic effect Effects 0.000 title description 23
- 239000000341 volatile oil Substances 0.000 claims description 91
- 235000008632 Santalum album Nutrition 0.000 claims description 72
- 230000001737 promoting effect Effects 0.000 claims description 37
- 239000003795 chemical substances by application Substances 0.000 claims description 28
- 239000004480 active ingredient Substances 0.000 claims description 9
- 230000037396 body weight Effects 0.000 claims description 7
- 235000005911 diet Nutrition 0.000 claims description 7
- 230000037213 diet Effects 0.000 claims description 7
- 235000015110 jellies Nutrition 0.000 claims description 7
- 235000014510 cooky Nutrition 0.000 claims description 6
- 235000014214 soft drink Nutrition 0.000 claims description 5
- 244000208874 Althaea officinalis Species 0.000 claims description 3
- 235000006576 Althaea officinalis Nutrition 0.000 claims description 3
- 235000009470 Theobroma cacao Nutrition 0.000 claims description 3
- 244000299461 Theobroma cacao Species 0.000 claims description 3
- 235000015895 biscuits Nutrition 0.000 claims description 3
- 235000001035 marshmallow Nutrition 0.000 claims description 3
- 241000221035 Santalaceae Species 0.000 claims 4
- 240000000513 Santalum album Species 0.000 description 68
- 230000000694 effects Effects 0.000 description 17
- 239000002775 capsule Substances 0.000 description 15
- 241001465754 Metazoa Species 0.000 description 13
- 239000003205 fragrance Substances 0.000 description 12
- 230000035882 stress Effects 0.000 description 12
- 230000001939 inductive effect Effects 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 9
- 210000001035 gastrointestinal tract Anatomy 0.000 description 9
- 206010022437 insomnia Diseases 0.000 description 9
- 239000003094 microcapsule Substances 0.000 description 9
- 239000003814 drug Substances 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 235000019640 taste Nutrition 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 7
- 238000010521 absorption reaction Methods 0.000 description 6
- 238000000222 aromatherapy Methods 0.000 description 6
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 108010010803 Gelatin Proteins 0.000 description 5
- 241000282412 Homo Species 0.000 description 5
- 102220547770 Inducible T-cell costimulator_A23L_mutation Human genes 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000008273 gelatin Substances 0.000 description 5
- 229920000159 gelatin Polymers 0.000 description 5
- 235000019322 gelatine Nutrition 0.000 description 5
- 235000011852 gelatine desserts Nutrition 0.000 description 5
- 230000003340 mental effect Effects 0.000 description 5
- 235000000346 sugar Nutrition 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000004623 sleep-prolonging effect Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 239000006188 syrup Substances 0.000 description 4
- 235000020357 syrup Nutrition 0.000 description 4
- 241000271566 Aves Species 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 230000002567 autonomic effect Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000013373 food additive Nutrition 0.000 description 3
- 239000002778 food additive Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 235000003642 hunger Nutrition 0.000 description 3
- 239000008274 jelly Substances 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000004006 olive oil Substances 0.000 description 3
- 235000008390 olive oil Nutrition 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- FTOAOBMCPZCFFF-UHFFFAOYSA-N 5,5-diethylbarbituric acid Chemical compound CCC1(CC)C(=O)NC(=O)NC1=O FTOAOBMCPZCFFF-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 2
- 241000699800 Cricetinae Species 0.000 description 2
- 208000020401 Depressive disease Diseases 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 244000042664 Matricaria chamomilla Species 0.000 description 2
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000003674 animal food additive Substances 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 235000014121 butter Nutrition 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000008451 emotion Effects 0.000 description 2
- 230000002996 emotional effect Effects 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 210000003715 limbic system Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 229940105631 nembutal Drugs 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 210000002475 olfactory pathway Anatomy 0.000 description 2
- 229960001412 pentobarbital Drugs 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 102220240796 rs553605556 Human genes 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 208000019116 sleep disease Diseases 0.000 description 2
- 230000004622 sleep time Effects 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 239000008399 tap water Substances 0.000 description 2
- 235000020679 tap water Nutrition 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- 239000003204 tranquilizing agent Substances 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- PJVXUVWGSCCGHT-ZPYZYFCMSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;(3s,4r,5r)-1,3,4,5,6-pentahydroxyhexan-2-one Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO PJVXUVWGSCCGHT-ZPYZYFCMSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 244000183685 Citrus aurantium Species 0.000 description 1
- 235000007716 Citrus aurantium Nutrition 0.000 description 1
- 240000007154 Coffea arabica Species 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000950647 Eremophila <Aves> Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 206010028817 Nausea and vomiting symptoms Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 235000011203 Origanum Nutrition 0.000 description 1
- 240000000783 Origanum majorana Species 0.000 description 1
- 241001093219 Osyris Species 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 235000006267 Salvia eremostachya Nutrition 0.000 description 1
- 241000122618 Salvia eremostachya Species 0.000 description 1
- 244000182022 Salvia sclarea Species 0.000 description 1
- 235000002911 Salvia sclarea Nutrition 0.000 description 1
- 235000008631 Santalum Nutrition 0.000 description 1
- 241001496113 Santalum Species 0.000 description 1
- 244000292638 Santalum lanceolatum Species 0.000 description 1
- 235000008026 Santalum lanceolatum Nutrition 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000973887 Takayama Species 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 229960002319 barbital Drugs 0.000 description 1
- HNYOPLTXPVRDBG-UHFFFAOYSA-N barbituric acid Chemical compound O=C1CC(=O)NC(=O)N1 HNYOPLTXPVRDBG-UHFFFAOYSA-N 0.000 description 1
- 239000010619 basil oil Substances 0.000 description 1
- 229940018006 basil oil Drugs 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 1
- 229960002327 chloral hydrate Drugs 0.000 description 1
- 239000000701 coagulant Substances 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000000517 effect on sleep Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000010656 jasmine oil Substances 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 201000003102 mental depression Diseases 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 210000000956 olfactory bulb Anatomy 0.000 description 1
- 210000001706 olfactory mucosa Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 229940124811 psychiatric drug Drugs 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 235000020071 rectified spirit Nutrition 0.000 description 1
- 230000028527 righting reflex Effects 0.000 description 1
- 102200004779 rs2232775 Human genes 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000008786 sensory perception of smell Effects 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- -1 sesquiterpene alcohols Chemical class 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 238000012876 topography Methods 0.000 description 1
- 229940125725 tranquilizer Drugs 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
- 238000004260 weight control Methods 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Landscapes
- Non-Alcoholic Beverages (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Fats And Perfumes (AREA)
- Fodder In General (AREA)
- Confectionery (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Description
【0001】[0001]
【発明の属する技術分野】本発明は、経口入眠促進剤及
び入眠促進用飲食物に関する。詳細には、本発明は、有
効成分としてビャクダン精油を含有することを特徴と
し、ストレスや精神的過敏症等によって正常な睡眠を得
られないヒトや動物に対して就眠や熟眠を促進する効果
をもたらす経口の入眠促進剤及び飲食物に関する。TECHNICAL FIELD [0001] The present invention relates to an oral insomnia promoting agent and
The present invention relates to foods for promoting sleep and falling asleep . More specifically, the present invention is characterized by containing sandalwood essential oil as an active ingredient, and has the effect of promoting sleep and deep sleep for humans and animals who cannot obtain normal sleep due to stress or mental irritability. The present invention relates to an oral sleep promoting agent and food and drink.
【0002】[0002]
【従来の技術】近年の産業の発達、それに伴う生活環境
の変化は「ストレス社会」という言葉の通り、人間やペ
ットを始めとする動物に対して物理的・心理的刺激すな
わち多くのストレスを生み出している。そしてこのよう
な社会の複雑化に伴って、器質病変等の具体的な病変が
見あたらないにもかかわわらず、寝付きが悪い、眠れな
い等といった不眠の症状を訴えるヒトが増えており、そ
の多くがストレスによるものと考えられている。2. Description of the Related Art In recent years, the development of industry and the accompanying changes in the living environment have resulted in physical and psychological stimuli, that is, a lot of stress on animals, including humans and pets, as the term "stress society." ing. As society becomes more complicated, more and more humans have complained of insomnia, such as difficulty falling asleep or not being able to sleep, even though specific lesions such as organic lesions are not found. Is thought to be due to stress.
【0003】この症状が重い場合、すなわち通院を要す
るような不眠症の治療薬としてはトランキライザーなど
の睡眠導入薬が使用されるが、これらの薬剤は劇物であ
り、しかも副作用が多いという欠点がある。[0003] When this symptom is severe, that is, as a remedy for insomnia that requires hospital visits, sleep-inducing drugs such as tranquilizers are used. However, these drugs are dramatic and have many drawbacks in that they have many side effects. is there.
【0004】一方、ヨーロッパ地方を中心に古くから知
られているアロマテラピーには、様々な精油の香りによ
る不眠の解消法が広く伝えられており(「実践アロマテ
ラピー」:シャーリ・プライス著、高山林太郎訳、1987
年)(「アロマテラピー」:ロバート・ティスランド
著、高山林太郎訳、1985年)、各研究分野においても、
香りが生理・心理状態に与える影響に関する報告が数多
く出されている。例えば、古賀による脳機能から見たア
ロマテラピーの効果についての報告(化学技術誌、1990
年8月)(フレグランス・ジャーナル、No.86、1987
年)や鳥居による香りと意識との関連についての報告
(フレグランス・ジャーナル、No.77、16、1986年)な
どである。また、ビターオレンジ精油やバジル油、ジャ
スミン油等の香りに入眠もしくは安眠促進作用があると
の報告もある(特開平4−128234号、特開平4−
149136号)。[0004] On the other hand, in aromatherapy which has been known for a long time mainly in the European region, a method of eliminating insomnia by various scents of essential oils has been widely reported ("practical aromatherapy": by Charli Price, Takayama Translated by Taro Hayashi, 1987
("Aromatherapy" by Robert Tisland, translated by Rintaro Takayama, 1985).
There have been many reports on the effects of scents on physiological and psychological states. For example, Koga reports on the effects of aromatherapy in terms of brain function (Chemical Technology, 1990
August) (Fragrance Journal, No.86, 1987)
) And a report on the relationship between scents and consciousness by torii gates (Fragrance Journal, No. 77, 16, 1986). It has also been reported that the fragrances of bitter orange essential oil, basil oil, jasmine oil and the like have a sleep-inducing or sleep-promoting effect (JP-A-4-128234, JP-A-4-128234).
149136).
【0005】しかしながら、これら従来の芳香療法によ
る鎮静、入眠促進効果等は、各精油が有する特有の香気
がヒトや動物の嗅覚を刺激することによって生じるもの
であり、香料の香りを鼻から嗅ぐという用いられ方に限
定されている。これは、従来から、抗ストレス・抗うつ
といった香りの作用機序に、脳嗅覚路の特異的な伝達路
が関与していると考えられていることによる。[0005] However, the sedation and sleep-inducing effects of these conventional fragrance therapies are caused by the odor of each essential oil stimulating the olfaction of humans and animals, and the scent of the fragrance is smelled from the nose. Limited to how they are used. This is because it has been conventionally thought that a specific transmission pathway of the brain olfactory pathway is involved in the mechanism of action of the fragrance such as anti-stress and antidepression.
【0006】大脳辺縁系は、本能、喜びや悲しみ及び怒
りや驚き等といった情動、また自律神経機能のコントロ
ールを担う器官であり、視床下部と密接に連絡しなが
ら、情動やそれに関連した身体反応に深く関わってい
る。かかる大脳辺縁系に、嗅球の僧帽細胞に発する嗅覚
路の二次神経元は直接入力しており、嗅覚で受けた刺激
(香り)は、情動や自律神経機能の制御に関わる大脳皮
質辺縁系で処理されるのである〔ストレスとアロマテラ
ピー、古賀良彦(フレグランス・ジャーナル、No.86、1
987年)、香りによるうつ病治療の試み−科学的検証と
臨床応用、小森、藤原ら(日本神経精神薬理学雑誌、Vo
l.15、39-42、1995)〕。[0006] The limbic system is an organ responsible for controlling instinct, joy, sadness, anger, surprise and the like, and autonomic nervous function. While closely communicating with the hypothalamus, the emotion and related physical reactions are involved. Is deeply involved in The secondary nervous system of the olfactory tract emanating from the mitral cells of the olfactory bulb is directly input to the limbic system, and the stimulus (scent) received by the olfactory sense is related to the control of emotions and autonomic nervous functions. [Stress and aromatherapy, Yoshihiko Koga (Fragrance Journal, No.86, 1
987), Trial of treatment of depression by fragrance-Scientific verification and clinical application, Komori, Fujiwara et al. (Japanese Journal of Neuropsychopharmacology, Vo)
l. 15, 39-42, 1995)].
【0007】一方で、香りに対する感受性及び「好き・
嫌い」等の嗜好性には、明らかな個体差があることも事
実である。好きな臭いを嗅いだ時には、気分が楽になっ
た、ほっとする、集中できる等の情緒的効果が得られる
のに対して、嫌いな臭いを嗅いだ時にはいらいらした
り、気持ちが悪くなったりする。また、嗜好に基づく情
緒的心理的要因が、α波を中心とした脳波変化、自律神
経機能などと大きく関わっていることも報告されている
〔香りと精神医学的臨床応用とその課題−神経精神生理
学的検討−、柳生隆視(FOOD & FOOD INGREDIENTS JOUR
NAL No.156, 1993)、脳波トポグラフィー、鳥居鎮夫
(フレグランス・ジャーナル、15-19, 1992-10)〕。On the other hand, sensitivity to fragrance and "like
It is also true that there is a clear individual difference in tastes such as “dislike”. When you smell the smell you like, you can get emotional effects such as ease of mood, relief, concentration, etc. On the other hand, smelling the smell you hate may be frustrating or uncomfortable. In addition, it has been reported that emotional and psychological factors based on tastes are greatly related to changes in electroencephalograms centered on α-waves, autonomic nervous functions, etc. [Scent and clinical application of psychiatry and its problems-neuropsychiatry] Physiological studies, Takami Yagyu (FOOD & FOOD INGREDIENTS JOUR
NAL No.156, 1993), EEG topography, Norio Torii (Fragrance Journal, 15-19, 1992-10)].
【0008】従って、個人の感受性や嗜好性等によって
影響されることなく催眠効果が安定して期待でき、かつ
従来睡眠薬として用いられているトランキライザー等と
は異なり副作用のない安全な安眠促進剤、催眠剤の開発
が望まれている。Accordingly, a hypnotic effect can be stably expected without being affected by individual sensitivity or taste, etc., and unlike a tranquilizer used conventionally as a sleeping pill, a safe sleep-promoting agent having no side effects, The development of agents is desired.
【0009】[0009]
【発明が解決しようとする課題】本発明は、ビャクダン
精油を有効成分として含有し、経口的に用いられること
を特徴とする経口入眠促進剤を提供することを目的とす
る。SUMMARY OF THE INVENTION An object of the present invention is to provide an oral sleep-inducing agent which contains sandalwood essential oil as an active ingredient and is used orally.
【0010】また本発明は、ビャクダン精油を含有する
ことを特徴とする入眠促進用飲食物を提供することを目
的とする。[0010] Another object of the present invention is to provide a food product for promoting sleep onset, characterized by containing sandalwood essential oil.
【0011】[0011]
【課題を解決するための手段】本発明者らは、上記従来
の問題を解決すべく鋭意研究を重ねていたところ、思い
がけずも、ビャクダン精油といった特定の精油が、従来
の嗅・口腔粘膜や肺からの吸収ではなく、経口的摂取に
よる消化管からの体内への吸収によって優れた催眠効果
を発揮することを見いだした。Means for Solving the Problems The inventors of the present invention have conducted intensive studies to solve the above-mentioned conventional problems. Unexpectedly, a specific essential oil such as sandalwood essential oil has been used for the conventional olfactory and oral mucosa. It has been found that an excellent hypnotic effect is exhibited by absorption into the body through the gastrointestinal tract by oral ingestion rather than absorption from the lungs.
【0012】ビャクダン精油は、アロマテラピー(芳香
療法)の分野でその芳香が不安症、抗うつ症に用いられ
ているが、その香気成分による安眠促進効果は殆ど期待
できないことが報告されている(特開平4−14913
6号)。また、線香のような芳香性ゆえに好き嫌いの個
人差が激しい。Although sandalwood essential oil is used for anxiety and antidepressant in the field of aromatherapy (aromatic therapy), it has been reported that its fragrance component can hardly be expected to have a good sleep promoting effect ( JP-A-4-14913
No. 6). Also, because of the aromatic nature of the incense, there is a strong individual difference between likes and dislikes.
【0013】これらの事実のもとで、本発明者らによる
上記知見はまさに驚くに値するものであった。本発明
は、この知見に基づいて開発されたものである。[0013] Under these facts, the above findings by the present inventors were just surprising. The present invention has been developed based on this finding.
【0014】すなわち本発明は、ビャクダン精油を有効
成分として含有することを特徴とする経口入眠促進剤で
ある。[0014] That is, the present invention is an oral sleep-inducing agent characterized by containing sandalwood essential oil as an active ingredient.
【0015】また本発明は、ビャクダン精油を含有する
ことを特徴とする入眠促進用飲食物である。[0015] The present invention is also a food and drink for promoting sleep onset, characterized by containing sandalwood essential oil.
【0016】[0016]
【0017】[0017]
【発明の実施の形態】経口入眠促進剤 本発明の経口入眠促進剤は、ビャクダン精油を有効成分
として含有するものであって、経口的に用いられて催眠
効果を奏するものであることを特徴とする。Oral sleep onset promoter oral sleep onset promoter present invention DETAILED DESCRIPTION OF THE INVENTION, and characterized by a one containing sandalwood essential oil as an active ingredient, it is intended to achieve the hypnotic effect used orally I do.
【0018】本発明で用いられるビャクダン精油として
は、例えばビャクダン科に属する東インド産のSant
alum album、オーストラリア産のEucar
uya spicata(またはSantalum s
picatum)、Santalum lanceol
atum、Eremophila mitchelli
または東アフリカ産のOsyris tenuifol
ia等の材と根を細断して水蒸気蒸留することによって
得ることのできる精油もしくはその同等物が挙げられ、
通常主成分としてα−サンダロール、β−サンダロール
を含むセスキテルペンアルコールが含まれている。また
その由来、産地は特に限定されず、上記のものの他、チ
モール、セレベス、マレー群島等の様々な産地のものを
使用することができる。The sandalwood essential oil used in the present invention includes, for example, Santant from East India belonging to the sandalwood family.
alum album, Eucar from Australia
uya spicata (or Santalum s)
picatum), Santalum lanceol
atum, Eremophila mitchelli
Or East African Osyris tenuifol
ia and the like, and essential oils that can be obtained by chopping the roots and steam distillation, or equivalents thereof,
Usually, sesquiterpene alcohols containing α-sandalol and β-sandalol as main components are contained. Further, the origin and place of production are not particularly limited, and those of various places of production such as Timor, Celebes, Malay Archipelago and the like can be used.
【0019】本発明の経口入眠促進剤は、かかるビャク
ダン精油を有効成分として含有するものであればよく、
含まれる精油の純度は、特に制限されるものではない。The oral sleep abstinence enhancer of the present invention may be any one containing such sandalwood essential oil as an active ingredient.
The purity of the essential oil contained is not particularly limited.
【0020】後述の実験例に示すように、本発明の入眠
促進剤の有効成分であるビャクダン精油は、ビャクダン
精油の香気が漏れないようにカプセルに封入して被験者
に投与した場合にも有意な催眠効果を発揮する。すなわ
ち、本発明の経口入眠促進剤の有効成分であるビャクダ
ン精油は、胃や小腸などの消化管から吸収されて、催眠
効果を奏するものである。従って、本発明の入眠促進剤
は、ビャクダン精油を胃や小腸等の消化管から吸収され
る形態で、すなわち消化管吸収成分として含有してお
り、経口的に摂取される形態に調製されていることが必
要である。As shown in the experimental examples described later, sleep onset of the present invention
Sandalwood essential oil, which is an active ingredient of the accelerator , exerts a significant hypnotic effect even when encapsulated in a capsule so as not to leak the fragrance of sandalwood essential oil and administered to a subject. That is, sandalwood essential oil, which is an active ingredient of the oral sleep-inducing agent of the present invention, is absorbed from the digestive tract such as the stomach and the small intestine, and exhibits a hypnotic effect. Therefore, the sleep attenuating agent of the present invention is prepared in a form in which sandalwood essential oil is absorbed from the gastrointestinal tract such as the stomach and the small intestine, that is, as a gastrointestinal absorption component, and is orally ingested. It is necessary.
【0021】また、ビャクダン精油の香気成分は、好き
嫌いの幅が広く、人によっては却って嫌悪感等の精神的
ストレスを覚える人もいる。かかる観点からも、本発明
の経口入眠促進剤は、人の嗜好性に影響されることなく
安定した催眠効果が期待できる点で極めて有用な催眠剤
である。The aroma component of sandalwood essential oil has a wide range of likes and dislikes, and some people may rather feel mental stress such as disgust. From this point of view, the oral sleep onset promoting agent of the present invention is very useful hypnotic agent in that it can expect stable hypnotic effect without being affected by the palatability of human.
【0022】本発明の入眠促進剤は経口的に摂取される
ものであれば、剤型は特に制限されないが、具体的には
錠剤、丸剤、顆粒状、粉末状、カプセル、マイクロカプ
セル、懸濁液状、液状、シロップ状、ゼリー状等が例示
され、使用目的や使用対象等に応じて適宜選択すること
ができる。好ましくは、カプセル、マイクロカプセル、
顆粒状、液状、シロップ状、ゼリー状の形態である。The form of the sleep-inducing agent of the present invention is not particularly limited as long as it can be taken orally. Specifically, tablets, pills, granules, powders, capsules, microcapsules, and suspensions A turbid liquid, a liquid, a syrup, a jelly, and the like are exemplified, and can be appropriately selected depending on a use purpose, a use target, and the like. Preferably, capsules, microcapsules,
Granules, liquids, syrups and jellies.
【0023】また、本発明の入眠促進剤の組成及び調製
方法等についても、前述するように特に制限されず、目
的に応じて適宜調製することができる。例えば、本発明
の入眠促進剤の組成に関しては、ビャクダン精油そのも
のであってもよいし、その他、賦形剤、崩壊剤、結合
剤、滑沢剤、矯臭剤、矯味剤、甘味剤、安定剤、ビタミ
ン剤、保存剤等の薬学的または食品衛生上許容される種
々の経口添加剤を含有していてもよい。The composition and preparation method of the sleep onset promoting agent of the present invention are not particularly limited as described above, and can be appropriately prepared according to the purpose. For example, with respect to the composition of the sleep onset promoting agent of the present invention, sandalwood essential oil itself may be used, or other excipients, disintegrants, binders, lubricants, flavoring agents, flavoring agents, sweeteners, stabilizers. And various oral additives that are pharmaceutically or food-sanitary acceptable such as vitamins and preservatives.
【0024】本発明の経口入眠促進剤は、バルビツール
酸系や抱水クロラール等の従来の催眠薬と比較して、植
物エキスを有効成分とし、投与初期の興奮作用や胃への
刺激性、及び翌日の後作用等といった副作用がなく、作
用が穏やかで安全範囲が広く、耐性や習慣性が少ないこ
とを特徴とする。The oral sleep abstinence enhancer of the present invention contains a plant extract as an active ingredient and has a stimulating action at the beginning of administration and a stimulus to the stomach, as compared with conventional hypnotics such as barbituric acid and chloral hydrate. It has no side effects such as post-effects on the following day, has a mild effect, has a wide safe range, and has low tolerance and habit.
【0025】したがって、医薬品としては勿論、医薬品
補助剤、食品添加剤、食品補助剤、餌料・飼料添加剤な
どとして広く用いることができる。すなわち、本発明の
経口入眠促進剤とは、入眠促進作用薬、入眠促進補助
薬、入眠促進用食品添加剤、入眠促進用食品補助剤、入
眠促進性餌料・飼料添加剤等を広く包括するものであ
る。Therefore, it can be widely used not only as pharmaceuticals but also as pharmaceutical auxiliaries, food additives, food auxiliaries, feed and feed additives, and the like. That is, the oral sleep onset promoter of the present invention, sleep onset promoting agents, sleep onset promoting adjuvants, sleep onset promoting food additive, sleep onset promoting food supplements, ON
It widely covers sleep-promoting feeds and feed additives.
【0026】本発明の経口入眠促進剤のビャクダン精油
の含有量は、特に制限されないが、後述の一投与あたり
の投与量を考慮して、通常0.0001〜100(w/
w)%の範囲から適宜選択される。The content of the sandalwood essential oil of the oral sleep promoting agent of the present invention is not particularly limited, but is usually 0.0001 to 100 (w / w) in consideration of the dose per one dose described below.
w) It is appropriately selected from the range of%.
【0027】本発明の経口入眠促進剤は、当該入眠促進
剤そのものをヒトまたは動物に投与してもよいし、また
医薬品、飲食物又は餌料等に添加・配合して用いること
もできる。[0027] Oral sleep onset promoting agent of the present invention to the sleep onset accelerator <br/> agent itself may be administered to a human or animal, also pharmaceuticals, also be used by admixing the food or feed, etc. it can.
【0028】本発明の入眠促進剤に含有されるビャクダ
ン精油の量は、これを適用する被験者の症状により或い
はその剤形などにより一定ではないが、投与単位形態あ
たり、経口剤で約3〜15000mgとするのが望まし
い。本発明の入眠促進剤は、通常1日1回もしくは2
回、就寝前の通常1時間〜30分前に服用されることが
好ましい。本発明の入眠促進剤の1回当たりの投与量
は、適用対象、ヒトもしくは動物の年齢、性別、症状等
によって異なるが、通常、ビャクダン精油の量として
0.1〜640mg/kg体重、好ましくは5〜320
mg/kg体重、より好ましくは45〜160mg/k
g体重の範囲の中から適宜選択することができる。The amount of sandalwood essential oil contained in the sleep-inducing agent of the present invention is not fixed depending on the condition of the subject to which it is applied or on its dosage form, but is about 3 to 15,000 mg per oral unit per dosage unit. It is desirable that The sleep onset promoting agent of the present invention is usually used once or twice a day.
It is preferably taken 1 to 30 minutes before bedtime. The dose of the sleep onset promoting agent of the present invention at one time varies depending on the application target, the age, sex, symptoms, etc. of the human or animal, but it is usually 0.1 to 640 mg / kg body weight, preferably as sandalwood essential oil, preferably, 5-320
mg / kg body weight, more preferably 45-160 mg / k
It can be appropriately selected from the range of g weight.
【0029】本発明の経口入眠促進剤は、広く睡眠障害
に対して適用することができるが、とりわけ精神的原
因、例えばストレス、不安、過労、憂鬱、興奮状態にな
っている場合における不眠症に有効である。また、本発
明の入眠促進剤は、生理的睡眠を誘発する効果(入眠促
進作用)と共に、睡眠時間を持続的に延長する効果(持
続性催眠作用)を有する。 [0029] The oral sleep-promoting agent of the present invention can be widely applied to sleep disorders, but especially for mental causes such as stress, anxiety, overwork, depression, and insomnia in a state of excitement. It is valid. In addition, the sleep onset promoting agent of the present invention has an effect of inducing physiological sleep (sleep inducing action) and an effect of continuously prolonging sleep time (continuous hypnotic action) .
【0030】本発明の経口入眠促進剤は、ヒトは勿論、
温血動物にも広く適用することができる。特に近年、屋
内で飼われているネコ、イヌ、ネズミ、ハムスター又は
トリ等のペットのストレス症が問題となっているが、か
かるペットのストレス性不眠症の改善に有効に用いるこ
とができる。この場合、カプセル剤やシロップ剤等とし
て本発明の経口入眠促進剤をそのまま投与してもよい
し、本発明の入眠促進剤を水や餌等に混合してペットに
投与してもよい。The oral sleep abstinence promoting agent of the present invention can be used not only for humans,
It can be widely applied to warm-blooded animals. In particular, in recent years, stress in pets such as cats, dogs, rats, hamsters, and birds kept indoors has become a problem, and it can be effectively used to improve stress insomnia in such pets. In this case, the oral sleep onset promoting agent of the present invention may be administered directly as capsules and syrups, sleep onset promoting agent of the present invention may be administered to the pet in admixture with water or food, or the like.
【0031】入眠促進用飲食物 後述の実験例で示すように、ビャクダン精油の催眠効果
はその消化管吸収によって奏されるものであり、また従
来医薬として用いられている催眠薬と比較して、副作
用、習慣性等の弊害が少なく安全であり、また作用が穏
やかで日常的に使用することができる。従って、ビャク
ダン精油を飲食物に配合することにより、催眠効果を奏
する入眠促進用飲食物を調製することができる。 Food and drink for promoting sleep onset As shown in the experimental examples described below, the hypnotic effect of sandalwood essential oil is exerted by its gastrointestinal absorption, and compared with hypnotics conventionally used as pharmaceuticals. It is safe with little adverse effects such as side effects and habits, and has a mild action and can be used on a daily basis. Therefore, by adding sandalwood essential oil to foods and drinks, it is possible to prepare foods and drinks for promoting sleep onset having a hypnotic effect.
【0032】食べるという行為は、精神的ストレスを緩
和する一つの方法であり、また空腹感によって寝付けな
い、目が醒めるといったことは誰しも経験するところで
ある。The act of eating is one way to relieve mental stress, and everyone experiences that they cannot sleep or wake up due to hunger.
【0033】かかる観点から、本発明は、「食べる」と
いうことにより精神的ストレスが緩和され、空腹感を満
たすという効果ともに、ビャクダン精油自身が消化管か
ら吸収されることによる催眠効果を有する入眠促進用飲
食物を提供するものである。From this point of view, the present invention provides the effect of "eating" to alleviate mental stress and satisfy the feeling of hunger, and to promote sleep onset which has a hypnotic effect by absorbing sandalwood essential oil itself from the digestive tract. there is provided a use drink <br/> food.
【0034】すなわち、本発明はビャクダン精油を含有
することを特徴とする入眠促進用飲食物を提供するもの
である。That is, the present invention provides a food / drink for promoting sleep onset characterized by containing essential oil of sandalwood.
【0035】ビャクダン精油としては、前述のものが例
示できる。The essential oils of sandalwood include those described above.
【0036】また、本発明の飲食物は、ビャクダン精油
が消化管から吸収される形態、すなわち消化管吸収成分
として配合・調製されているものであればよく、その限
りにおいて組成、形態、調製方法などは特に制限されな
い。The food and drink of the present invention may be in any form as long as sandalwood essential oil is absorbed from the digestive tract, that is, formulated and prepared as a gastrointestinal absorption component. Is not particularly limited.
【0037】例えば、本発明が対象とする飲食物の種類
は、ビャクダン精油の催眠作用が損なわれないものであ
れば特に制限されず、クッキー、ビスケット、ゼリー、
飴、マシュマロ等の菓子類、ヨーグルト、麺類等の食
品、清涼・炭酸飲料、牛乳、ココア、紅茶、コーヒー、
アルコール類などの飲料もしくは嗜好品を広く対象とす
ることができる。For example, the types of foods and drinks targeted by the present invention are not particularly limited as long as the hypnotic effect of sandalwood essential oil is not impaired, and cookies, biscuits, jellies,
Sweets such as candy and marshmallows, foods such as yogurt and noodles, refreshing and carbonated drinks, milk, cocoa, tea, coffee,
A wide range of beverages or luxury items such as alcohols can be targeted.
【0038】好ましくは、ダイエット用飲食物である。
ここでダイエット用飲食物とは、体重調節のため栄養や
カロリーを配慮した飲食物をいい、具体的には、一食あ
たりのカロリーが、通常0〜100キロカロリー、好ま
しくは0〜40キロカロリー、より好ましくは、0〜3
キロカロリーの範囲にあるものであり、より具体的に
は、このカロリー範囲にあるクッキー、ビスケット、ゼ
リー、マシュマロ、清涼飲料またはココア等が挙げられ
る。Preferably, it is a diet food or drink.
Here, food and drink for diet refers to food and drink in consideration of nutrition and calories for weight control, specifically, the calorie per meal is usually 0 to 100 kcal, preferably 0 to 40 kcal, more preferably Is 0-3
It is in the kilocalorie range, and more specifically, cookies, biscuits, jellies, marshmallows, soft drinks or cocoa, etc. in this calorie range.
【0039】かかる本発明の入眠促進用のダイエット飲
食物は、不眠が、ダイエットからくる精神的抑圧や空腹
感を一因とする場合等に、肥満への恐怖感や罪悪感なく
安心して食べることができ、また食べることによるスト
レス緩和効果をも奏することできる点で有用である。The diet and drink for promoting sleep onset of the present invention can be eaten without fear of obesity or guilt when obstruction is caused by mental depression or hunger caused by the diet. It is useful in that it can also exert a stress relieving effect by eating.
【0040】また本発明の飲食物によれば、薬物とは異
なり、加齢とともに減少する睡眠時間のため不眠(軽度
の睡眠障害)に悩む高齢者であっても抵抗無く摂取でき
る。Further, according to the food and drink of the present invention, unlike drugs, even elderly people who suffer from insomnia (mild sleep disorder) can take it without resistance due to the decrease in sleep time with aging.
【0041】本発明の飲食物の調製方法もまた制限され
ず、通常用いられる食品・飲料組成物中にビャクダン精
油を配合して、クッキー等の菓子類や清涼飲料水などを
調製しても良いし、また牛乳、アルコール類等の既製の
飲食物にビャクダン精油そのものもしくは前述の経口入
眠促進剤を食品添加剤等として添加、配合することによ
り調製してもよい。The method for preparing the food and drink of the present invention is not limited either, and confectioneries such as cookies and soft drinks may be prepared by blending sandalwood essential oil into a commonly used food or beverage composition. and, also milk, sandalwood essential oil itself or the above-mentioned oral entering the ready-made food, such as alcohols
It may be prepared by adding and blending a sleep promoting agent as a food additive or the like.
【0042】本発明の入眠促進用飲食物の催眠性成分で
あるビャクダン精油は、消化管から吸収されて徐々にそ
の効果を奏するものであり、本発明の入眠促進用飲食物
は、通常就寝前2時間〜30分前に摂取することが好ま
しい。[0042] is a hypnotic component of sleep onset promoting food of the present invention sandalwood essential oil is absorbed from the gastrointestinal tract is intended that gradually achieve the effect, sleep onset promoting food of the present invention, prior to normal sleeping Preferably, it is taken 2 hours to 30 minutes before.
【0043】また、含有されるビャクダン精油の形態
も、消化管で吸収される形態であれば特に制限されず、
飲食物の種類によって適宜選択することができる。例え
ば、精油そのままの形態であってもよいし、粉末状、顆
粒状、マイクロカプセル状、シロップ状などの種々の形
態に調製されていてもよい。ただし、飲食物にビャクダ
ン精油を0.5重量%以上含有させる場合は、ビャクダ
ン精油の臭いや味の不快さを減じて飲食物自身の呈味性
を損なわないよう、精油の臭い・味を封じこめた形態、
好ましくはマイクロカプセル状の形態として含有させる
ことが望ましい。The form of essential oil contained in sandalwood is not particularly limited as long as it is absorbed in the digestive tract.
It can be appropriately selected depending on the type of food and drink. For example, the essential oil may be used as it is, or may be prepared in various forms such as powder, granule, microcapsule, and syrup. However, when the food and drink contain more than 0.5% by weight of sandalwood essential oil, the smell and taste of the essential oil are sealed so as to reduce the unpleasant odor and taste of sandalwood essential oil and not impair the taste of the food and drink itself. The form
Preferably, it is desirable to include them in the form of microcapsules.
【0044】また、ビャクダン精油が消化管から吸収さ
れる態様である限り、飲食物の芳香性については特に制
限されず、飲食物の種類やその風味・呈味性、また対象
者の嗜好に応じて適宜選択できる。よって本発明の飲食
物は、ビャクダン精油に由来する香気を呈するものであ
っても、また呈しないものであってもよい。As long as the essential oil of sandalwood is absorbed from the digestive tract, the aromaticity of the food and drink is not particularly limited, and it depends on the type of food and drink, its flavor and taste, and the taste of the subject. Can be selected as appropriate. Therefore, the food and drink of the present invention may or may not have an aroma derived from sandalwood essential oil.
【0045】本発明の入眠促進用飲食物に含まれるビャ
クダン精油の量は、食品の種類等によって相違するが、
通常0.005〜20重量%、好ましくは0.01〜1
2重量%、より好ましくは0.1〜5重量%である。The amount of sandalwood essential oil contained in the food for promoting sleep onset of the present invention varies depending on the type of food and the like.
Usually 0.005 to 20% by weight, preferably 0.01 to 1%
It is 2% by weight, more preferably 0.1 to 5% by weight.
【0046】摂取量としては、飲食者の年齢、性別、不
眠の症状等のよっても相違するが、通常精油として一食
あたり0.1〜40mg/kg体重、好ましくは1〜2
0mg/kgの範囲が挙げられる。The amount of intake varies depending on the age, sex, insomnia symptoms, etc. of the food and drink, but is usually 0.1 to 40 mg / kg body weight per serving as essential oil, preferably 1 to 2 mg / kg.
The range is 0 mg / kg.
【0047】入眠促進性餌料 また、前述のビャクダン精油は、経口投与による催眠効
果を期待して動物の餌料に適用することができる。 Sleep-promoting feed The above-mentioned sandalwood essential oil can be applied to animal feed, expecting a hypnotic effect by oral administration.
【0048】すなわち、本発明はビャクダン精油を含有
することを特徴とする入眠促進性餌料を提供するもので
ある。That is, the present invention provides a sleep-promoting diet containing sandalwood essential oil.
【0049】餌料とは、一般に動物を成長させ、また飼
育するための食物・飲料物を指すものであるが、本発明
においてはかかる目的に限定されず、動物に与える食
物、飲用物を広く包含する趣旨で用いられる。The term "feed" generally refers to foods and drinks for growing and breeding animals, but the present invention is not limited to such purposes and broadly includes foods and drinks to be given to animals. Used for the purpose.
【0050】また、本発明の餌料が対象とする動物は、
動物の種類によって制限されるものではなく、あらゆる
温血動物、即ちトリや哺乳動物を含むものであるが、具
体的にはイヌ、ネコ、サル、トリ、ネズミ、ハムスター
等のペットや家畜が例示される。Also, the animal to which the diet of the present invention is directed is
It is not limited by the type of animal, but includes all warm-blooded animals, that is, birds and mammals, and specifically includes pets and livestock such as dogs, cats, monkeys, birds, rats, and hamsters. .
【0051】本発明の餌料は、ビャクダン精油を消化管
から吸収される形態で、言い換えれば消化管吸収成分と
して含有するものであればよく、形態、その他の組成、
調製方法等は特に制限されない。The feed of the present invention may be in a form in which sandalwood essential oil is absorbed from the gastrointestinal tract, in other words, as long as it contains a gastrointestinal absorption component.
The preparation method and the like are not particularly limited.
【0052】一般に、通常用いられる飼料・餌料もしく
は飼料・餌料組成物(天然飼料・餌料、人工飼料・餌料
の別を問わない。)に適宜配合して、調製することがで
きる。 ビャクダン精油の含有量は、動物の種類、年
齢、体重等に応じて異なり、適宜選択・変更することが
できる。通常餌料一食あたり、精油として、40〜65
0mg/kg、好ましくは160〜300mg/kg摂
取されるように、餌料一食あたり、精油0.5〜30重
量%、好ましくは1〜20重量%の範囲で選択される。In general, it can be prepared by appropriately mixing with a commonly used feed / feed or feed / feed composition (regardless of whether it is a natural feed / feed or an artificial feed / feed). The content of sandalwood essential oil varies depending on the type, age, body weight, etc. of the animal, and can be appropriately selected and changed. Usually 40-65 as an essential oil per meal
The essential oil is selected in the range of 0.5 to 30% by weight, preferably 1 to 20% by weight per meal, so that 0 mg / kg, preferably 160 to 300 mg / kg is ingested.
【0053】以下に本発明の実施例、参考例を示すが、
これらの例は単に本発明を説明するためのものであっ
て、本発明はこれらに限定されるものではない。Examples of the present invention and reference examples will be shown below.
These examples are merely for illustrating the present invention, and the present invention is not limited thereto.
【0054】[0054]
【実施例】実施例1(カプセル) 40〜60℃に加温したゼラチン5gを攪拌しながら徐
々に添加し、混合溶解する。その混合溶液を減圧脱泡し
た後、酸化チタン、色素を適量加えて更に混合する。そ
の後、カプセル型ビンに充填し、成形した後水分が15
〜18%になるまで乾燥させ、カプセルのbody部にビャ
クダン精油200mgを充填し、cap部を結合させて、
ビャクダン精油を200mg含有するカプセル剤を調製
した。EXAMPLES Example 1 (Capsule) 5 g of gelatin heated to 40 to 60 ° C. is gradually added with stirring, and mixed and dissolved. After defoaming the mixed solution under reduced pressure, appropriate amounts of titanium oxide and a dye are added and further mixed. Then, after filling into a capsule type bottle and molding, the water content is reduced to 15
1818% dried, filled with 200 mg of sandalwood essential oil in the body of the capsule, combined with the cap,
A capsule containing 200 mg of sandalwood essential oil was prepared.
【0055】実施例2(マイクロカプセル) 40℃に加温した精製水100gに対し、ゼラチン5g
を攪拌しながら徐々に添加し、混合溶解する。その後、
ビャクダン精油200mg、酸化チタン、グリセリン、
色素を適量加え、混合してカプセルを得る。その後カプ
セルを冷却後、15〜18%になるまで脱水し、更に水
分が8.2〜16%になるまで乾燥した。その後、ろ過
して、ビャクダン精油を含有するマイクロカプセルを調
製した。 Example 2 (microcapsules) 5 g of gelatin was added to 100 g of purified water heated to 40 ° C.
Is added slowly with stirring, and mixed and dissolved. afterwards,
Sandalwood essential oil 200mg, titanium oxide, glycerin,
An appropriate amount of dye is added and mixed to obtain a capsule. Thereafter, the capsule was cooled and dehydrated until the water content became 15 to 18%, and further dried until the water content became 8.2 to 16%. Thereafter, filtration was performed to prepare microcapsules containing sandalwood essential oil.
【0056】実施例3(クッキー) 下記の配合量を用いて次の方法でビャクダン精油を含有
するクッキーを調製した。 薄力粉 200g 無塩バター 70g 砂糖(グラニュー糖) 80g 卵 1 個ビャクダン精油 2 g まずバターを攪拌し、そして攪拌しながら砂糖を徐々に
添加した。この中に割ほぐした卵を添加した後、ビャク
ダン精油を添加し、速度を落として更に攪拌した。十分
混ざった段階で、均一にふるった薄力粉をこれに加え
て、低速で攪拌した後、一つにまとめる。これを、約3
0分間低温室に寝かした後、約1cmの厚みで均一にのば
し、直径5cmの円形型で抜く。次いで、切り抜いたクッ
キー生地を天版に並べ、精油の揮散を防ぐため、生地表
面にオリーブ油を塗り、170℃で予熱したオーブンで
12〜15分間加熱し、ビャクダン精油を含有するクッ
キーを調製した。[0056]Example 3 (cookie) Contains sandalwood essential oil by the following method using the following amount
Cookies were prepared. Soft flour 200g Unsalted butter 70g Sugar (granulated sugar) 80g 1 eggSandalwood essential oil 2 g First, stir the butter, then slowly add the sugar while stirring
Was added. After adding the cracked egg into this,
Dan essential oil was added, and the mixture was further stirred at a reduced speed. sufficient
When mixed, add the evenly sifted flour to this
After stirring at low speed, combine them into one. This is about 3
After lying in a low-temperature room for 0 minutes, spread it evenly with a thickness of about 1 cm.
Then, pull out with a 5 cm diameter circular mold. Next,
Arrange the key dough on the top plate and use a dough table to prevent evaporation of essential oils.
Apply olive oil on the surface and in an oven preheated at 170 ° C
Heat for 12-15 minutes and cook with sandalwood essential oil.
The key was prepared.
【0057】実施例4(清涼飲料水) 下記の配合に従って、清涼飲料水を調製した。 Example 4 (Soft drink) Soft drink was prepared according to the following formulation.
【0058】 果糖ブドウ糖液糖 6.0重量部 クエン酸ナトリウム 0.6 L−アスコルビン酸 3.0 ビャクダン精油 0.5水 適当量 全 量 100 重量部実施例5(紅茶) 紅茶の葉1.2mgを100mlの湯(80℃)に入れ
て、十分浸漬した後、デカンテーションして浸出液を得
る。この浸出液中に砂糖5g及びビャクダン精油0.5
gを入れ、全部で100mlとした。Fructose-glucose liquid sugar 6.0 parts by weight Sodium citrate 0.6 L-ascorbic acid 3.0 Sandalwood essential oil 0.5 water Suitable amount total amount 100 parts by weight Example 5 (tea) Black tea leaves 1.2 mg Is put in 100 ml of hot water (80 ° C.), sufficiently immersed, and then decanted to obtain a leachate. 5 g of sugar and 0.5 of sandalwood essential oil were added to this leachate.
g was added to make a total of 100 ml.
【0059】実施例6(ゼリー) 50mlの水を約60℃に加熱した後、ゼラチンを添加
し攪拌する。ゼラチンが溶解した後、攪拌しながら他の
材料を加えて、全てが溶解した後、容器に流し込み、低
温室にて冷やし固め、ビャクダン精油0.5重量%を含
有するゼリーを調製した。 Example 6 (Jelly) After heating 50 ml of water to about 60 ° C., gelatin was added and stirred. After the gelatin was dissolved, the other ingredients were added with stirring, and after everything was dissolved, the mixture was poured into a container, cooled and solidified in a low-temperature room, and a jelly containing 0.5% by weight of sandalwood essential oil was prepared.
【0060】 砂糖 22.0重量部 L−酒石酸 0.1 クエン酸ナトリウム 0.1 ゼラチン 1.1 クエン酸 0.1 ビャクダン精油 0.5水 適当量 全 量 100 重量部実施例7(アルコール類) ニュートラルスピリッツ 30.0重量部 ステピオサイト 0.1 香料 5.0 ビャクダン精油 0.3水 適当量 全 量 100 重量部実施例8(ペットフード) 実施例2と同様な方法でビャクダン精油を60重量%含
有するマイクロカプセルを調製した。次いで、下記の割
合で当該マイクロカプセルを配合して、ビャクダン精油
を5.4重量%含有する餌料(ペットフード)を調製し
た。Sugar 22.0 parts by weight L-tartaric acid 0.1 sodium citrate 0.1 gelatin 1.1 citric acid 0.1 sandalwood essential oil 0.5 water suitable amount total amount 100 parts by weight Example 7 (alcohols) Neutral spirits 30.0 parts by weight Stepiosite 0.1 Fragrance 5.0 Sandalwood essential oil 0.3 Water Suitable amount total amount 100 parts by weight Example 8 (pet food) Sandalwood essential oil 60 weight by the same method as Example 2 % Microcapsules were prepared. Next, the microcapsules were blended at the following ratio to prepare a feed (pet food) containing 5.4% by weight of sandalwood essential oil.
【0061】 牛肉(20×20×20mmのダイズ状カット) 80.0重量部 凝固剤(カラギーナン) 2.0 食塩 0.1 ビャクダン精油入りマイクロカプセル 9.0 水 適当量 合 計 100.0重量部 [0061] Beef (20 × 20 × 20 mm soybean shaped cut) 80.0 parts by weight of coagulant (carrageenan) 2.0 saline 0.1 sandalwood essential oil-filled microcapsules 9.0 water appropriate amount Total 100.0 parts by weight
【0062】[0062]
【実験例】実験例1:バルビタール睡眠延長試験 −実験例A− 被験精油として、ビャクダン(Sandalwood)、マージョラ
ム(Marjorum)、カモミール(Chamomile)、ローズ(Ros
e)、クラリセージ(Clary Sage)、ベルベナ(Velbena)、
及び酢酸リナリル(Lynaryl Acetate)(それぞれ、長岡
香料株式会社製)を用いて、これらそれぞれをddy系
雄性マウスに600mg/kgずつ経口投与することに
より、これら精油の睡眠延長作用を比較実験した。[Experimental Examples] Experimental Example 1: Barbital sleep prolongation test -Experimental example A-As test essential oils, sandalwood, Marjorum, chamomile, rose (Ros)
e), Clary Sage, Velbena,
And dynyl acetate (Lynaryl Acetate) (each manufactured by Nagaoka Aroma Co., Ltd.) were orally administered to male ddy mice at a dose of 600 mg / kg each, and the sleep prolonging effect of these essential oils was compared.
【0063】使用するddy系雄性マウス動物(日本エ
スエルシー)は、入荷後温度21〜25℃、湿度48〜
65%、照明時間12時間(7:00〜19:00)の
条件に設定した飼育室で、固形試料F−2(船橋農場)
及び水道水(水道水質基準に適合)を自由に摂取させ飼
育した。マウスは、肉眼で健康状態を観察して異常のな
い動物のみを収容して、入荷時より3日以上予備飼育し
た後、更に一般状態の健康なものを使用した。The ddy male mouse animal (Japan SLC) used had a temperature of 21 to 25 ° C and a humidity of 48 to
Solid sample F-2 (Funabashi Farm) in a breeding room set under the conditions of 65%, lighting time 12 hours (7:00 to 19:00)
And tap water (conforming to tap water quality standards) was freely taken and bred. The mice were housed only with no abnormalities by observing their health condition with the naked eye, and preliminarily reared for 3 days or more from the time of arrival, and then used in more general condition.
【0064】実験には、かかる6週齢(体重27〜32
g)のマウスを1群10匹として使用した。The experiment was conducted at the age of 6 weeks (weight 27-32).
The mice in g) were used as 10 mice per group.
【0065】実験は溶媒(オリーブ油:コントロール)
または被験液(ビャクダン精油等の被験精油)を経口投
与後30分に、ペントバルビタール(ネンブタール:大
日本製薬製)45mg/kgを腹腔投与し、側歐姿勢か
ら自発的に腹位に戻る前の時間を麻酔時間として測定し
た。The experiment was conducted using a solvent (olive oil: control).
Alternatively, 30 minutes after oral administration of a test solution (test essential oil such as sandalwood essential oil), 45 mg / kg of pentobarbital (Nembutal: manufactured by Dainippon Pharmaceutical) was intraperitoneally administered, and before returning spontaneously from the lateral posture to the abdominal position. The time was measured as the anesthesia time.
【0066】結果を表1に示す。Table 1 shows the results.
【0067】[0067]
【表1】 [Table 1]
【0068】各精油間で催眠効果を比較したところ、ビ
ャクダン精油に顕著な睡眠延長作用が認められ、また個
体差による効果の差も殆どなかった。一方、マージョラ
ム、カモミール、ローズ、クラリセージは個体差が大き
く、延長作用を示すものとそうでないものあり、精油に
よる睡眠延長作用を確認することが出来なかった。When the hypnotic effects of the essential oils were compared, a remarkable sleep-prolonging effect was observed in sandalwood essential oil, and there was almost no difference in effect due to individual differences. On the other hand, marjoram, chamomile, rose, and clary sage showed large individual differences, some of which exhibited prolonging action and those of which did not, so that the sleep prolonging action of essential oil could not be confirmed.
【0069】−実験例B− 実験例Aで用いた精油のうち、顕著な催眠効果が認めら
れたビャクダン精油について、2.5〜640mg/k
g体重の範囲で投与量を変えて、実験例Aと同様の実験
を行った。-Experimental Example B- Of the essential oils used in Experimental Example A, sandalwood essential oil having a remarkable hypnotic effect was 2.5 to 640 mg / k.
The same experiment as in Experimental Example A was performed except that the dose was changed within the range of g body weight.
【0070】結果を表2に示す。Table 2 shows the results.
【0071】[0071]
【表2】 [Table 2]
【0072】ビャクダン精油の40mg/kg以上の投
与から睡眠延長作用が顕著に認められた。The sleep prolonging effect was remarkably recognized from the administration of sandalwood essential oil at a dose of 40 mg / kg or more.
【0073】実験例2 入眠促進作用 実験例1と同様な系を用いて、マウスに、被験液(ビャ
クダン精油、体重1kgあたりの用量として2.5m
g、10mg、40mg、160mg、640mgを使
用)又はコントロールとして溶媒(オリーブ油)を経口
投与した後30分後に、ペントバルビタール(ネンブタ
ール:大日本製薬製)45mg/kgを腹腔投与した
後、正向反射が消失するまでの時間を測定し、それを入
眠時間として評価した。 EXPERIMENTAL EXAMPLE 2 Using the same system as in Experimental Example 1, the mice were treated with a test solution (sandalwood essential oil, 2.5 m / kg body weight).
g, 10 mg, 40 mg, 160 mg, and 640 mg) or as a control, 30 minutes after oral administration of a solvent (olive oil), and 45 mg / kg of pentobarbital (Nembutal: manufactured by Dainippon Pharmaceutical) intraperitoneally, followed by righting reflex. The time until disappearance was measured and evaluated as sleep onset time.
【0074】結果を図1に示す。FIG. 1 shows the results.
【0075】この実験から、ビャクダン精油の投与によ
り寝入りの時間が有意に短縮されることが確認された。From this experiment, it was confirmed that the administration of sandalwood essential oil significantly reduced the bedtime.
【0076】実験例3 寝付きが悪いとか不眠症を不満に有する成人からランダ
ムに3名を選択し、これらを被験者として、下記の配合
で調製したビャクダン精油を含有するカプセルを服用し
てもらい、睡眠に対する影響を検討した。 Experimental Example 3 Three adults were randomly selected from adults who were uncomfortable with falling asleep or complaining of insomnia, and these were used as subjects to take capsules containing the essential oil of sandalwood prepared with the following formulation and sleep. The effect on was examined.
【0077】催眠効果は下記の評価項目について、実験
実施以前の状態と比較して5段階で評価した。The hypnotic effect was evaluated on the following evaluation items on a scale of 1 to 5 in comparison with the state before the experiment.
【0078】・評価項目: (i)寝付き、(ii)眠りの深さ、(iii)睡眠中の目覚め、(i
v)目覚めの状態 ・評価:いつもと比べて A:良かった、B:やや良かった、C:変わらなかっ
た、D:やや悪かった、E:悪かった なお、服用時間は就寝前30分〜1時間とし、服用の
際、アルコールや他の精神神経用薬との併用を避けるこ
とを指示した。Evaluation items: (i) falling asleep, (ii) depth of sleep, (iii) awakening during sleep, (i)
v) Awake state ・ Evaluation: Compared to usual A: Good, B: Somewhat good, C: No change, D: Somewhat bad, E: Bad In addition, taking time is 30 minutes to 1 before bedtime They were instructed to avoid taking alcohol and other psychiatric drugs when taking the drug.
【0079】カプセル剤:硬質カプセルに、ビャクダン
精油200mgを香気が漏れないように封入してビャク
ダン精油を含有する経口用剤を調製した。Capsules: An oral preparation containing essential oil of sandalwood was prepared by enclosing 200 mg of sandalwood essential oil in a hard capsule without leaking aroma.
【0080】結果を表3に示す。Table 3 shows the results.
【0081】[0081]
【表3】 評 価 A B C D E (i) 寝付き 3 0 0 0 0(人数) (ii) 眠りの深さ 3 0 0 0 0 (iii)睡眠中の目覚め 3 0 0 0 0 (iv) 目覚めの状態 2 1 0 0 0 表3から明らかなように、被験者のいずれに対してもビ
ャクダン精油含有剤による催眠効果が認められた。な
お、3名のうち1名には、ビャクダン精油を2日おきに
3回服用してもらって、睡眠の状況を調べた。この結
果、いずれの項目についてもAの評価を得た。[Table 3 ] Evaluation ABCDE (i) Sleeping 300 000 (number of people) (ii) Depth of sleep 300 000 (iii) Awakening during sleep 300 000 (iv) Awake state 2100 As is clear from Table 3, the hypnotic effect of the sandalwood essential oil-containing agent was observed for all of the subjects. One of the three patients took sandalwood essential oil three times every two days to check the state of sleep. As a result, all items were evaluated as A.
【0082】さらに同時に、被験者に服用した際、もし
くはその翌日に下記のような症状が現れなかったかどう
かについてアンケートを採った。At the same time, a questionnaire was taken as to whether the following symptoms did not appear when the subject took it or on the following day.
【0083】・動悸がした/めまいがする/発疹した/
倦怠感を感じた/頭痛がした/悪心がした/嘔吐した/
下痢をした/口が渇いた/翌日、日中に眠気を覚えた/
翌日、倦怠感が残った。Palpitations / vertigo / rash /
Fatigue / Headache / Nausea / Vomiting /
Diarrhea / Mouth thirst / The next day, I felt drowsy during the day /
The next day, fatigue remained.
【0084】その結果、いずれの項目にも該当する被験
者は一人もいなかった。As a result, none of the subjects corresponded to any of the items.
【0085】このことから、本発明の入眠促進剤は、催
眠効果(入眠促進、催眠持続性、安眠)を奏するのみな
らず、後作用を含めて副作用を示さない安全なものであ
るといえる。From this, it can be said that the sleep onset promoting agent of the present invention not only has a hypnotic effect (promoting sleep onset, maintaining hypnosis, and sleeping well) but is also safe without any side effects including post-action.
【0086】また、比較実験として、ビャクダン精油の
投与と同様の方法で、オレンジ精油含有カプセル(20
0mg/カプセル)を調製し、これを就寝前30分〜1
時間に服用してもらって睡眠に対する影響を検討した。
その結果、寝付き、眠りの深さ、及び目覚めの状
態については、実験実施前と「変わらず」、また睡眠
中の目覚めに関しては、いつもより「悪かった」という
結果が得られた。As a comparative experiment, capsules containing orange essential oil (20 capsules) were prepared in the same manner as in the administration of sandalwood essential oil.
0 mg / capsule) and prepare it for 30 minutes before bedtime.
The effect on sleep was examined by having the patient take the drug at time.
As a result, with respect to the state of falling asleep, the depth of sleep, and the state of awakening, the result was “no change” from before the experiment, and the result of waking up during sleep was “worse” than usual.
【図1】実験例2で行ったビャクダン精油の入眠促進作
用を見た結果を示す図である。FIG. 1 is a view showing the results obtained by examining the sleep-inducing effect of sandalwood essential oil performed in Experimental Example 2.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI A23L 1/307 A23L 1/307 2/00 A61K 9/48 A61K 9/48 A61P 25/20 A61P 25/20 C11B 9/00 A C11B 9/00 A23L 2/00 Z (58)調査した分野(Int.Cl.7,DB名) A61K 35/78 A23G 3/00 A23L 1/30 A23L 2/00 A61K 9/48 C11B 9/00 BIOSIS(DIALOG) CA(STN)──────────────────────────────────────────────────の Continued on the front page (51) Int.Cl. 7 Identification code FI A23L 1/307 A23L 1/307 2/00 A61K 9/48 A61K 9/48 A61P 25/20 A61P 25/20 C11B 9/00 A C11B 9/00 A23L 2/00 Z (58) Fields investigated (Int. Cl. 7 , DB name) A61K 35/78 A23G 3/00 A23L 1/30 A23L 2/00 A61K 9/48 C11B 9/00 BIOSIS (DIALOG) CA (STN)
Claims (6)
ことを特徴とする経口入眠促進剤。1. An oral sleep abstinence promoting agent comprising sandalwood essential oil as an active ingredient.
640mg/kg体重の範囲で含む請求項1記載の経口
入眠促進剤。2. The essential oil of sandalwood is used in an amount of 0.1 to 0.1 mg per administration.
The oral hypnotic agent according to claim 1, which is contained in a range of 640 mg / kg body weight.
る入眠促進用飲食物。3. A food or drink for promoting sleep onset, comprising essential oil of sandalwood.
の範囲で含有する請求項3記載の入眠促進用飲食物。4. The essential oil of sandalwood is 0.005 to 20% by weight.
The food / drink for promoting sleep onset according to claim 3, which is contained in the range of:
求項3又は4記載の入眠促進用飲食物。5. The food or drink for promoting sleep onset according to claim 3 or 4, wherein the food or drink is a food or drink for diet.
ー、マシュマロ、清涼飲料及びココアの中から選択され
るものである請求項3乃至5のいずれかに記載の入眠促
進用飲食物。6. The food for promoting sleep onset according to any one of claims 3 to 5, wherein the food or drink is selected from cookies, biscuits, jellies, marshmallows, soft drinks and cocoa.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP18234996A JP3240345B2 (en) | 1996-07-11 | 1996-07-11 | Oral hypnotics, hypnotic foods and drinks |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP18234996A JP3240345B2 (en) | 1996-07-11 | 1996-07-11 | Oral hypnotics, hypnotic foods and drinks |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH1025245A JPH1025245A (en) | 1998-01-27 |
| JP3240345B2 true JP3240345B2 (en) | 2001-12-17 |
Family
ID=16116765
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP18234996A Expired - Lifetime JP3240345B2 (en) | 1996-07-11 | 1996-07-11 | Oral hypnotics, hypnotic foods and drinks |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3240345B2 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001058435A1 (en) * | 2000-02-10 | 2001-08-16 | Kao Corporation | Autonomic controlling agents |
| JP5306160B2 (en) * | 2001-08-08 | 2013-10-02 | 株式会社 資生堂 | Use of a specific fragrance component for producing a fragrance composition for mental sedation, and a method for imparting a mental sedative effect in the fragrance composition |
| WO2007013581A1 (en) * | 2005-07-28 | 2007-02-01 | Kobayashi Pharmaceutical Co., Ltd. | Sedative composition |
| GB0620279D0 (en) * | 2006-10-13 | 2006-11-22 | Reckitt Benckiser Uk Ltd | Compositions |
| GB2461091A (en) * | 2008-06-20 | 2009-12-23 | Compton Developments Ltd | Using a sandalwood extract or analogue as an animal foodstuff additive |
| CN109259013A (en) * | 2018-09-03 | 2019-01-25 | 赣州市七道皇文化发展有限公司 | A kind of pure natural spice beverage and preparation method thereof |
-
1996
- 1996-07-11 JP JP18234996A patent/JP3240345B2/en not_active Expired - Lifetime
Non-Patent Citations (1)
| Title |
|---|
| Phytomedicine,vol.2,n0.2,p119−126,1995 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH1025245A (en) | 1998-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5686615B2 (en) | A deep sleep disorder improving agent containing glycine | |
| JP4951162B2 (en) | Sleep improvement composition | |
| US20180104299A1 (en) | Use of saffron and/or safranal and/or crocin and/or picrocrocin and/or derivatives thereof as a satiation agent for the treatment of obesity | |
| JP6100692B2 (en) | Sleep quality improver | |
| WO2013051728A1 (en) | Agent for improving quality of sleep | |
| JP2003183174A (en) | Insomnia composition | |
| JP3240345B2 (en) | Oral hypnotics, hypnotic foods and drinks | |
| JPH1025246A (en) | Oral hypnotic agent, hypnotic beverage and food, and hypnotic feed | |
| JP2011153125A (en) | Autonomic control agent containing pseudo-leaf of asparagus as active ingredient | |
| WO2007042745A1 (en) | Chocolate based appetite suppressant | |
| CN106470691A (en) | Comprise cinnamic aldehyde and the compositionss of zinc and the using method of such composition | |
| TWI784169B (en) | Prevention or improvement agent for nocturnal frequent urination | |
| TWI530256B (en) | Method for producing anti-mental fatigue agent utilizing ferro-bound lactoferrin | |
| JP2005289948A (en) | Sleep improvement composition | |
| JP6864964B2 (en) | Oral sleep improver | |
| JP4435882B2 (en) | Alcohol absorption inhibiting composition | |
| JP7317256B1 (en) | Agent for improving concentration and/or information processing ability | |
| WO2008080810A2 (en) | Composition comprising cocoa fibre | |
| WO2025023322A1 (en) | Activity improver and food and drink for improving activity | |
| JP2005325086A (en) | Agent for preventing and/or treating sleep disturbance, functional food or cosmetic | |
| JP2006333872A (en) | Food containing glycine and use thereof | |
| CN114343182A (en) | Fish oil microcapsule composition and preparation method and application thereof | |
| KR20240146137A (en) | Sensory activator composition, sensory activator including the same and method of fabricating thereof | |
| JP2008044885A (en) | Composition for internal use for fatigue prevention and preparation for internal use for fatigue prevention | |
| KR20220165292A (en) | Sensory activator composition and Sensory activator including the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20071019 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121019 Year of fee payment: 11 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20131019 Year of fee payment: 12 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |